Pfizer Inc. (PFE) 10-Q Filing 2026-03-28

📊 Key Financial Highlights

Revenue

$13.58B

2026-03-28

Net Income

$-3.73B

2026-03-28

EPS (Basic)

$-0.73

Per share

Total Assets

$205.33B

Balance sheet

Operating Cash Flow

$1.10B

Cash flow statement

Gross Margin

39.4%

Profitability

📋 Filing Information

Company	Pfizer Inc.
Ticker	PFE
Form Type	10-Q
Period of Report	2026-03-28
Filing Date	2026-04-24
Sector	Healthcare
CIK Number	0000050863

📄 View Full SEC Filing →

📝 Filing Summary

            This is a Quarterly Report (10-Q) filed by Pfizer Inc. with the SEC. It covers the quarter ending 2026-03-28 and includes unaudited financial statements and management discussion.
        

Pfizer Inc. (PFE) operates in the Healthcare sector. The company reported revenue of $13.58B and net income of $-3.73B for the period ending 2026-03-28. The filing was submitted to the Securities and Exchange Commission (SEC) on 2026-04-24.

Investors and analysts use 10-Q filings to assess financial health, identify trends, and make investment decisions. Key areas to review include revenue growth, profit margins, cash flow generation, and management's outlook.

🔗 Explore More on emfls.github.io

Discover more financial analysis and guides:

🇰🇷 Korean Stock Analysis ₿ Crypto Reports 📊 All SEC Filings ✈️ Travel Guides 🎮 QuickPlay Arcade